S-nitrosylated and pegylated hemoglobin, a newly developed artificial oxygen carrier, exerts cardioprotection against ischemic hearts
Hiroshi Asanuma(Meiji University of Integrative Medicine), Masafumi Kitakaze(Hanwa Memorial Hospital), Ichiro Sakuma(Hokko Memorial Hospital), Masanori Asakura(National Cerebral and Cardiovascular Center), Jiyoong Kim(National Cerebral and Cardiovascular Center), Kazuo Komamura, Kunihiko Nakai(National Institute for Minamata Disease), Masakatsu Wakeno(Kindai University), Shoji Sanada(Kobe University Hospital), Masashi Fujita(Osaka International Cancer Institute), Seiji Takashima(The University of Osaka), Akio Hirata(The University of Osaka), Masatsugu Hori(Osaka National Hospital), Akira Kitabatake(Hokkaido University), Hiroyuki Takahama(Tohoku University), Tetsuo Minamino(Kagawa University), Hisakazu Ogita(Shiga University of Medical Science)
Cited by 23
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system
|Journal of Clinical Investigation|2007|1k
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
|Nature Medicine|2002|722
Right Ventricular Function in Heart Failure With Preserved Ejection Fraction
|Circulation|2014|456
Metformin Prevents Progression of Heart Failure in Dogs
|Circulation|2009|288